Jilin Zixin Pharmaceutical Co., Ltd.
Announcement No.: 2023-077
The company and all members of the board guarantee that the content of this information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Special Reminder:
- According to Article 9.2.1 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," as of June 8, 2023, the company's stock closing price was 0.47 CNY/share, and the stock price has been below 1 CNY for fifteen consecutive trading days. Even if the stock price rises to the daily limit for the next five trading days, it will still trigger the delisting indicators due to the stock price being below 1 CNY for twenty consecutive trading days. If this occurs, the Shenzhen Stock Exchange will make a decision to terminate the listing of the company's stock within the prescribed period, and the stock will not enter a delisting transition period.
- According to Article 9.2.3 of the "Shenzhen Stock Exchange Stock Listing Rules (2023 Revision)," the company must disclose the risk warning announcement regarding the potential termination of listing due to the stock price being below par value, and subsequently disclose it every trading day until the relevant situation is resolved or until the Shenzhen Stock Exchange makes a decision to terminate the listing of the company's stock. Investors are advised to invest rationally and pay attention to risks.